All In Biotech

Free tool

FAERS Monitor: Kuvan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022181 or its brand name (Kuvan, Sapropterin Dihydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,907

Serious

1,042

18% of reports

Hospitalization

415

Death reported

72

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective358
  • headache358
  • therapy non-responder356
  • vomiting291
  • maternal exposure during pregnancy281
  • diarrhoea269
  • nausea218
  • amino acid level increased209
  • abdominal pain upper198
  • anxiety184
  • abdominal discomfort166
  • cough150
  • arthralgia148
  • dizziness147
  • nasopharyngitis141

Reports by year received

View as table
YearReports
200831
200999
2010194
201166
201257
201350
2014356
2015387
2016459
2017564
2018521
2019726
2020583
2021550
2022340
2023332
2024308
2025175
2026109

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,252 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
amino acid level increasedSignal2091394.61190.9208,191
therapy non-responderSignal35628.425.79,336
maternal exposure during pregnancySignal28111.310.02,619
abdominal discomfortSignal1663.53.0300
abdominal pain upperSignal1983.43.0341
nasopharyngitisSignal1412.72.3153
anxietySignal1842.32.0136
vomitingSignal2912.22.0195
headacheSignal3582.01.8193
cough1501.91.664
diarrhoea2691.51.343
arthralgia1481.31.18
dizziness1471.00.90
nausea2181.00.90
drug ineffective3581.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.